Manhattan Scients
Manhattan Scientifics, Inc., a technology incubator, engages in the acquisition, development, and commercialization of life-enhancing technologies in the United States. It develops technologies in the areas of nano-technologies and nano-medicine. The company also offers nanostructured bulk metals and alloys in the form of rod, bar, wire, and foil for medical implants and other applications. The c… Read more
Manhattan Scients (MHTX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2024: 0.007x
Based on the latest financial reports, Manhattan Scients (MHTX) has a cash flow conversion efficiency ratio of 0.007x as of June 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-17.00K) by net assets ($-2.34 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Manhattan Scients - Cash Flow Conversion Efficiency Trend (1999–2023)
This chart illustrates how Manhattan Scients's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Manhattan Scients Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Manhattan Scients ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
DongBang Medical
KQ:240550
|
N/A |
|
Cryomass Technologies Inc
OTCQX:CRYM
|
0.030x |
|
Finnovate Acquisition Corp. Warrants
NASDAQ:FNVTW
|
-0.011x |
|
Bee Vectoring Technologies International Inc
PINK:BEVVF
|
-0.012x |
|
Shinhan WTI Futures ETN(H)
KO:500015
|
N/A |
|
NORDIC AMER TANKER
MU:B3O
|
0.062x |
|
Sayward Capital Corp
V:SAWC-P
|
0.176x |
|
COLOR STAR TECH. DL-001
F:2J4A
|
N/A |
Annual Cash Flow Conversion Efficiency for Manhattan Scients (1999–2023)
The table below shows the annual cash flow conversion efficiency of Manhattan Scients from 1999 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | $-1.80 Million | $-190.00K | 0.105x | -48.79% |
| 2022-12-31 | $-1.70 Million | $-349.00K | 0.206x | +150.62% |
| 2021-12-31 | $1.03 Million | $-421.00K | -0.407x | -390.00% |
| 2020-12-31 | $4.67 Million | $-388.00K | -0.083x | -126.40% |
| 2019-12-31 | $-1.00 Million | $-316.00K | 0.314x | -93.08% |
| 2018-12-31 | $-150.00K | $-682.00K | 4.547x | +4790.94% |
| 2017-12-31 | $8.16 Million | $-791.00K | -0.097x | +94.21% |
| 2016-12-31 | $2.72 Million | $-4.56 Million | -1.674x | -521.24% |
| 2015-12-31 | $8.59 Million | $3.42 Million | 0.397x | -86.96% |
| 2014-12-31 | $-832.00K | $-2.54 Million | 3.047x | +607.36% |
| 2013-12-31 | $-2.24 Million | $-964.00K | 0.431x | -68.15% |
| 2012-12-31 | $-797.00K | $-1.08 Million | 1.353x | +104.18% |
| 2011-12-31 | $37.00K | $-1.20 Million | -32.324x | -596.76% |
| 2010-12-31 | $71.00K | $462.00K | 6.507x | +1259.11% |
| 2009-12-31 | $-848.00K | $-406.00K | 0.479x | -42.41% |
| 2008-12-31 | $-842.00K | $-700.00K | 0.831x | +66.12% |
| 2007-12-31 | $-1.07 Million | $-537.00K | 0.500x | +260.46% |
| 2006-12-31 | $-2.38 Million | $-331.00K | 0.139x | -69.27% |
| 2005-12-31 | $-1.66 Million | $-751.00K | 0.452x | +82.37% |
| 2004-12-31 | $-1.80 Million | $-445.00K | 0.248x | +14.41% |
| 2003-12-31 | $-1.16 Million | $-251.00K | 0.217x | -85.32% |
| 2002-12-31 | $-633.00K | $-934.00K | 1.476x | +194.02% |
| 2001-12-31 | $1.51 Million | $-2.37 Million | -1.569x | -12.70% |
| 2000-12-31 | $2.87 Million | $-3.99 Million | -1.393x | -200.94% |
| 1999-12-31 | $3.22 Million | $-1.49 Million | -0.463x | -- |